P3 Health Partners Inc. (NASDAQ:PIII - Get Free Report) was the target of a significant decrease in short interest during the month of April. As of April 15th, there was short interest totalling 85,500 shares, a decrease of 97.2% from the March 31st total of 3,080,000 shares. Currently, 4.7% of the shares of the stock are short sold. Based on an average daily volume of 18,800 shares, the days-to-cover ratio is presently 4.5 days.
P3 Health Partners Trading Down 1.3 %
NASDAQ PIII traded down $0.12 during trading hours on Thursday, hitting $8.87. The company's stock had a trading volume of 2,848 shares, compared to its average volume of 20,308. The stock has a fifty day moving average of $8.96 and a 200 day moving average of $11.43. P3 Health Partners has a twelve month low of $7.00 and a twelve month high of $40.50. The firm has a market capitalization of $63.70 million, a P/E ratio of -10.56 and a beta of 0.96. The company has a quick ratio of 0.53, a current ratio of 0.53 and a debt-to-equity ratio of 1.11.
P3 Health Partners (NASDAQ:PIII - Get Free Report) last announced its quarterly earnings data on Thursday, March 27th. The company reported ($16.00) earnings per share for the quarter, missing the consensus estimate of ($8.50) by ($7.50). The business had revenue of $370.69 million during the quarter, compared to analyst estimates of $378.88 million. P3 Health Partners had a negative net margin of 6.95% and a negative return on equity of 71.31%. Equities research analysts forecast that P3 Health Partners will post -0.67 earnings per share for the current fiscal year.
Institutional Investors Weigh In On P3 Health Partners
Hedge funds have recently bought and sold shares of the company. Geode Capital Management LLC raised its holdings in P3 Health Partners by 115.2% in the third quarter. Geode Capital Management LLC now owns 1,029,259 shares of the company's stock worth $398,000 after purchasing an additional 550,925 shares during the period. Trinity Financial Advisors LLC acquired a new stake in P3 Health Partners in the fourth quarter worth $261,000. Sanders Morris Harris LLC raised its holdings in P3 Health Partners by 50.0% in the fourth quarter. Sanders Morris Harris LLC now owns 184,497 shares of the company's stock worth $41,000 after purchasing an additional 61,499 shares during the period. Abundance Wealth Counselors raised its holdings in P3 Health Partners by 77.3% in the first quarter. Abundance Wealth Counselors now owns 400,000 shares of the company's stock worth $66,000 after purchasing an additional 174,395 shares during the period. Finally, Wealthedge Investment Advisors LLC acquired a new stake in P3 Health Partners in the fourth quarter worth $83,000. 7.75% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Separately, Lake Street Capital decreased their price target on shares of P3 Health Partners from $50.00 to $20.00 and set a "buy" rating on the stock in a research note on Monday, April 21st.
Check Out Our Latest Analysis on P3 Health Partners
P3 Health Partners Company Profile
(
Get Free Report)
P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.
Featured Stories
Before you consider P3 Health Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and P3 Health Partners wasn't on the list.
While P3 Health Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.